Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ryman Healthcare Group Ltd. buy tbackenh

Start price
€7.98
13.07.21 / 80%
Target price
€10.00
13.07.22
Performance (%)
-31.03%
End price
€5.50
13.07.22
Summary
This prediction ended on 13.07.22 with a price of €5.50. Massive losses of -31.03% were the result for the BUY prediction by tbackenh. tbackenh has 80% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ryman Healthcare Group Ltd. -5.130% -5.130% -29.839%
iShares Core DAX® -0.922% -1.078% 12.165%
iShares Nasdaq 100 0.371% -0.556% 38.622%
iShares Nikkei 225® 2.224% -2.825% 19.015%
iShares S&P 500 -0.026% -0.788% 28.485%

According to tbackenh what are the pros and cons of Ryman Healthcare Group Ltd. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
Some uniques
Known brand
Top 10 in its market
Future proof or reliable business model
Cons

Comments by tbackenh for this prediction

In the thread Ryman Healthcare Group Ltd. diskutieren
Prediction Buy
Perf. (%) -31.03%
Target price 10.000
Change
Ends at 13.07.22

Buy mit Kursziel 10,0

In the thread Trading Ryman Healthcare Group Ltd.
Prediction Buy
Perf. (%) -31.03%
Target price 10.000
Change
Ends at 13.07.22

Die von tbackenh gewählte maximale Laufzeit wurde überschritten

Stopped prediction by tbackenh for Ryman Healthcare Group Ltd.

buy
Ryman Healthcare Group Ltd.

Start price
Target price
Perf. (%)
€6.82
27.05.19
€7.75
08.07.19
6.01%
08.07.19

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management